Related Experiment Video

Updated: Aug 18, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

[Antithrombotic therapy during percutaneous coronary interventions]

F W A Verheugt1, H Dieker, W R M Aengevaeren

  • 1Universitair Medisch Centrum St Radboud, afd. Cardiologie, Postbus 9101 6500 HB Nijmegen. f.verheugt@cardio.umcn.nl

Nederlands Tijdschrift Voor Geneeskunde
|May 12, 2005
PubMed

Insights

Antithrombotic therapy, including aspirin, clopidogrel, and heparin, is crucial for preventing complications during percutaneous coronary interventions. Extended clopidogrel use is recommended for patients with drug-eluting stents.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Pharmacology

Background:

  • Antithrombotic therapy is vital for preventing peri-procedural death and myocardial infarction during percutaneous coronary interventions (PCI).
  • Commonly used agents include aspirin, clopidogrel, and heparin for patients undergoing angioplasty or stenting.

Purpose of the Study:

  • To outline the essential role and common agents of antithrombotic therapy in percutaneous coronary interventions.
  • To specify indications for glycoprotein IIb/IIIa receptor antagonists and extended clopidogrel use.

Main Methods:

  • Review of current antithrombotic strategies in percutaneous coronary interventions.
  • Identification of key pharmacological agents and their specific indications.

Main Results:

  • Aspirin, clopidogrel, and heparin are standard antithrombotic agents for PCI.
  • Glycoprotein IIb/IIIa antagonists are indicated for high-risk patients and specific acute coronary syndromes.
  • Extended clopidogrel duration (beyond 30 days) is recommended for drug-eluting stents.

Conclusions:

  • Appropriate antithrombotic therapy selection and duration are critical for optimizing outcomes in PCI.
  • Tailoring antithrombotic regimens based on patient risk and stent type improves safety and efficacy.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...